“标本配穴法”联合西药治疗稳定性心绞痛的疗效观察

发布时间：2018-05-24 12:04

本文选题：标本配穴法 + 针刺治疗　；参考：《广州中医药大学》2016年硕士论文

【摘要】：目的：目前关于中西医结合治疗稳定性心绞痛的临床研究有很多,穴位针刺治疗是其中一种,有关穴位配伍的方法众说纷繁。本课题旨在研究“标本配穴法”联合西药治疗冠心病稳定性心绞痛的临床疗效。方法：纳入60例冠心病稳定性心绞痛病人,均来自2015年8月至2016年2月期间在广东省中医院心脏中心住院的病人,将其随机分为试验组与对照组。对照组的患者按照冠心病二级预给予西药治疗,试验组病人在标准西药治疗基础上加用穴位针刺治疗,取穴方法采用“标本配穴法”,选取双足三里、双内关、关元。比较两组病人治疗前后在中医症候计分、心绞痛分级、心绞痛积分、西雅图心绞痛量表及SF一36量表评分方面的变化情况。结果：治疗后,试验组中医证候总计分较对照组下降更明显,两组差异具有统计学意义(P＜0.05),表明试验组中医证候改善情况明显优于对照组。两组患者在治疗后,心绞痛积分均较治疗前有所改善,两组间比较,试验组在改善心绞痛症状方面优于对照组,差异具有统计学意义(P＜0.05)。生存质量方面,经7天治疗,SAQ各维度计分,试验组患者在“心绞痛稳定状态”、“心绞痛发作情况”、 “治疗满意程度”方面与对照组比较均有非常显著的差异(P＜0.01),而在“躯体活动受限程度”、“疾病认识程度”两个方面两组无显著差别(P＞0.05)。试验组SF-36各维度计分均高于对照组,组间比较显示,试验组患者在改善“生理功能”、“生理职能”、“健康变化”方面要优于对照组(P＜0.05)试验组和对照组两组病人在治疗前后均无任何不良反应发生。结论：应用“标本配穴法”联合西药治疗冠心病稳定性心绞痛可以有效改善病人心绞痛症状,并提高其生活质量,且安全有效。
[Abstract]:Objective: there are many clinical studies on the treatment of stable angina pectoris with the combination of traditional Chinese and western medicine. The purpose of this study is to study the clinical effect of "specimen matching method" combined with western medicine in the treatment of stable angina pectoris of coronary heart disease. Methods: sixty patients with stable angina pectoris of coronary heart disease from August 2015 to February 2016 were randomly divided into trial group and control group. The patients in the control group were treated with western medicine in accordance with the second stage of coronary heart disease, the patients in the test group were treated with acupuncture at acupoints on the basis of standard western medicine treatment, and the points were taken with the method of "specimen matching acupoint", and double Zusanli, Shuangneiguan and Guanyuan were selected. The changes of TCM symptom score, angina pectoris grade, angina pectoris score, Seattle angina scale and SF 36 scale before and after treatment were compared between the two groups. Results: after treatment, the total score of TCM syndromes in the experimental group was significantly lower than that in the control group, and the difference between the two groups was statistically significant (P < 0.05), which indicated that the improvement of TCM syndromes in the experimental group was obviously better than that in the control group. The scores of angina pectoris in the two groups were improved after treatment. Compared with the control group, the symptoms of angina pectoris in the experimental group were better than those in the control group, the difference was statistically significant (P < 0.05). In terms of quality of life, after 7 days of treatment, the patients in the trial group were in stable state of angina pectoris. There were significant differences between the two groups in terms of "angina attack" and "therapeutic satisfaction" (P < 0.01), but there was no significant difference between the two groups in the "degree of physical activity restriction" and "degree of disease awareness" (P > 0.05). The scores of SF-36 in each dimension of the trial group were higher than those in the control group. The comparison between the two groups showed that the patients in the test group were improving their "physiological function" and "physiological function". "Health change" was better than that of control group (P < 0.05). No adverse reactions occurred before and after treatment in both the test group and the control group. Conclusion: it is safe and effective to treat stable angina pectoris of coronary heart disease by using "specimen matching method" combined with western medicine to improve the symptoms of angina pectoris and improve the quality of life.
【学位授予单位】：广州中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R541.4

【相似文献】